

Explore by topic
Airbus Group (AIR.XETRA) — 5‑year timeline (2020–2026). Latest price (2026‑07‑07): 203.9
| Major company- and stock-specific events that likely moved the price (earnings surprises, guidance changes, product/strategy shifts, M&A, regulatory events, management changes, major macro shocks, etc.) | How public and investor perception and narrative around the stock evolved over this period (e.g. "hype growth story", "turnaround", "value trap", "defensive compounder") | Key technical phases on the chart over roughly the last 5 years: big uptrends/downtrends, sideways ranges, breakouts/breakdowns, retests of important levels, and unusually large drawdowns or rallies | |---|---|---| | 31‑Jan‑2020 — Record global bribery/corruption settlement: Airbus agreed coordinated resolutions with French PNF, UK SFO and US DOJ/DoS (~€3.6bn provision), booked as a large one‑off and subject to monitoring/conditions [47][43]. | Immediate investor concern about corporate governance, big one‑off earnings impact and legal overhang; stock carried a governance risk premium into 2020. [47][43] | Pre‑COVID trade was near an all‑time high in Jan‑2020 (~€139); the settlement added downside vulnerability ahead of the pandemic shock. [1] | | Mar–Apr‑2020 — COVID crisis: factory suspensions (France/Spain), delivery deferrals, guidance withdrawn, dividend suspended; liquidity measures (new €15bn credit facility; €2.5bn bond) and production‑rate cuts for A320/A330/A350 families as demand collapsed. Q1 2020 reported sharp profit decline and heavy cash burn. [2][7][11][4] | Stock narrative shifted to "survival / liquidity" and extreme cyclicality; investors focused on cash preservation, delivery cadence and balance‑sheet actions. [7][11][4] | Massive drawdown: share plunge to €49.07 on 18‑Mar‑2020 (~65% from Jan peak); extreme volatility and the single largest structural decline in the window. [1] | | Jun‑2020 → 2021 — Stabilisation & managed ramp: Airbus adapted production/delivery plans (delivered 566 commercial aircraft in 2020 while cutting capex and conserving cash), gradually restarted deliveries and worked supplier network. [1][11] | Perception shifted toward "value / early recovery" as travel demand signalled gradual return; investors tracked delivery ramp & cashflow improvement. [6][1] | Partial V‑recovery from the March low into mid‑2020 (~€84 on 9‑Jun‑2020) followed by extended consolidation through 2020–2021 as recovery visibility remained uncertain. [6][1] | | Nov‑2021 → 2022 — A350 surface/paint & quality issues escalate: operators reported surface degradation; regulators and carriers scrutinised A350 condition; Qatar grounded/blocked some A350s and cancelled further deliveries — dispute escalated publicly and threatened delivery/orders overhang. [23][18][19][15] | Narrative shifted to "quality/operational risk" with fresh downside risk: investors worried about compensation, delivery interruptions and reputational damage. [23][15] | Stock underperformed / traded sideways to weaker through late‑2021 into 2022 while the dispute remained unresolved — a new negative catalyst overlaying the recovery case. [23][15] | | 01‑Feb‑2023 — Airbus & Qatar settle A350 dispute: parties announce amicable settlement, repair programme and reinstatement of previously cancelled A350/A321neo orders (details confidential); legal overhang removed. [28][35][34] | Immediate improvement in sentiment: removal of a major legal/delivery overhang was widely read as a de‑risking catalyst for deliveries and order backlog monetisation. [28][35] | Relief rally / positive momentum shift in early 2023 — market re‑rated execution and delivery visibility into the recovery thesis. [3][34] | | 2022–2023 (supply‑chain era) — Managed production ramp and delivery targets: Airbus moderated narrowbody acceleration due to supplier constraints and re‑established a 720 deliveries target for 2023 while acknowledging lost time in recovery; core profitability for the prior year improved (management commentary). [3] | Narrative shifted from "turnaround" to "managed ramp / execution": investors concentrated on backlog conversion vs supplier execution risk. [3] | Gradual uptrend through 2022–2023 punctuated by news‑driven pullbacks tied to supply‑chain updates; execution beats provoked further rallies. [3][39] | | Full‑year 2023 (reported 14‑Feb‑2024) — Demand rebound: gross commercial aircraft orders 2,319 and net orders 2,094; 735 deliveries in 2023; order backlog ~8,598 aircraft — clear evidence of demand & backlog strength. [39][33] | Re‑rating to a demand‑led recovery story; market narrative matured to "recovery compounder" / delivery‑driven revenue growth rather than residual pandemic risk. [39] | Multi‑quarter breakout and sustained uptrend through 2023 as orders/deliveries materially beat pandemic‑era expectations; reduced structural downside. [39] | | Jul–Nov‑2024 — A321XLR programme milestones: EASA Type Certificate for CFM‑powered A321XLR issued 19‑Jul‑2024; FAA certification followed (early Oct‑2024); first customer deliveries (Iberia) and entry‑into‑service Oct/Nov‑2024 — major product catalyst for long‑range single‑aisle market. [60][70][66][59] | Product‑catalyst narrative strengthened: A321XLR validated Airbus' competitive edge in long‑range single‑aisle and supported medium‑term revenue/delivery profile. [60][66] | Event‑driven breakouts and renewed technical acceleration around certification and delivery announcements; positive technical confirmation of the recovery trend. [60][66] | | Sep‑2024 — A350‑1000 engine incident & regulatory checks: a Cathay Pacific A350‑1000 engine fire prompted EASA precautionary inspections/ADs focused on A350‑1000 components (visual checks/measurements) and short‑term operational checks. [24][27] | Short‑term safety / regulatory overhang for the A350‑1000 sub‑type; investors temporarily cautious pending investigation outcomes and corrective actions. [24][27] | Short‑term volatility and retest of support levels (news‑driven), but limited structural damage where inspections were procedural/light; reflation resumed once issues were contained. [24][27] | | 21‑Feb‑2025 → mid‑2026 — Programme maturation & continued ramp: Pratt & Whitney‑powered A321XLR type certification completed (Feb‑21‑2025), enabling full‑engine‑choice deliveries; Airbus continued ramp planning toward pre‑pandemic target rates as backlog converted to deliveries. [65][69][22] | By 2025–mid‑2026 narrative consolidated into "recovery + execution": backlog provided multi‑year visibility; investors rewarded execution and product roll‑outs (A321XLR). | Sustained multi‑year uptrend since 2022 with periodic news‑led pullbacks; the 2020 drawdown remains the largest historical drawdown in the window — as of 2026‑07‑07 the stock is trading at 203.9. [39][65] |
Airbus Group spans commercial aircraft, helicopters, defence and space, competing globally against large OEMs, major defence contractors and specialised engine and systems suppliers. Boeing remains the primary commercial rival, though regional manufacturers like Embraer and state-backed competitors such as COMAC exert pressure. Suppliers including Safran, Rolls-Royce and Raytheon Technologies shape both margins and technology trajectories. The business faces structural headwinds: cyclical airline demand and order volatility, the inherent complexity of global supply chains and production execution, currency and financing exposure, and regulatory or geopolitical constraints that can defer deliveries or close markets entirely.
Airbus Group commands leading positions across commercial aircraft, helicopters, and defence/space. It competes directly with Boeing in large commercial airliners and faces formidable competition from U.S. and European defence primes—Lockheed Martin, RTX, Northrop, Thales, Dassault, Textron. The portfolio's diversity (commercial, defence/space, helicopters) exposes the company to cyclical airline demand, structural pricing pressure within the duopoly, and the vulnerabilities embedded in complex multinational supply chains. Production execution and supplier reliability remain persistent pressure points, alongside programme cost discipline and the layered risks of regulatory, geopolitical, and compliance environments [Airbus, Boeing, Lockheed, RTX, Thales, Dassault Wikipedia pages].
| Company | Ticker |
|---|---|
| The Boeing Company | BA.NYSE |
| Lockheed Martin Corporation | LMT.NYSE |
| RTX Corporation | RTX.NYSE |
| Northrop Grumman Corporation | NOC.NYSE |
| Textron Inc. | TXT.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Airbus SE | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +15.25% | +13.54% | +13.84% |
| 3M | +21.54% | +16.37% | +11.28% |
| 6M | -3.43% | -2.55% | -11.73% |
| 1Y | +15.90% | +12.47% | -5.97% |
| 3Y | +64.93% | +4.46% | -12.05% |
| 5Y | +97.10% | +37.50% | +13.41% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 32.1 | 2.2 | 6.2 | 27.2 |
| 1Y ago | 28.4 | 2.0 | 6.1 | 22.7 |
| 3Y ago | 26.7 | 1.7 | 6.8 | 15.6 |
| 5Y ago | 28.6 | 1.6 | 9.3 | 9.6 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 3.20 EUR | 1.81% | 1.79% |
| 2025 | 3.00 EUR | 2.20% | |
| 2024 | 2.80 EUR | 1.71% | |
| 2023 | 1.80 EUR | 1.41% | |
| 2022 | 1.50 EUR | 1.42% | |
| 2020 | 1.80 EUR | 3.17% | |
| 2019 | 1.65 EUR | 1.39% | |
| 2018 | 1.50 EUR | 1.64% | |
| 2017 | 1.35 EUR | 1.89% | |
| 2016 | 1.30 EUR | 2.38% | |
| 2015 | 1.20 EUR | 1.93% | |
| 2014 | 0.75 EUR | 1.41% | |
| 2013 | 0.60 EUR | 1.35% | |
| 2012 | 0.45 EUR | 1.72% | |
| 2012 | 0.39 EUR | 1.45% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 73.42B | 69.23B | 65.45B | 58.76B | 52.15B |
| Operating income (EBIT) | 5.24B | 4.80B | 4.27B | 4.74B | 4.83B |
| Net income | 5.22B | 4.23B | 3.79B | 4.25B | 4.21B |
| Free cash flow | 4.42B | 3.93B | 3.35B | 3.82B | 2.79B |
| Total assets | 134.94B | 129.21B | 118.87B | 115.94B | 107.05B |
| Equity | 26.10B | 19.61B | 17.70B | 12.95B | 9.47B |
| Net debt | 2.17B | -3.73B | -5.15B | -4.84B | -1.11B |